Variant report

Variant	rs881916
Chromosome Location	chr2:20631396-20631397
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr2:20630112..20632871-chr2:20634105..20637084,2	K562	blood:
2	chr2:20629036..20632108-chr2:20636280..20640164,4	MCF-7	breast:
3	chr2:20624768..20627663-chr2:20631096..20633713,2	MCF-7	breast:
4	chr2:20631193..20635788-chr2:20642965..20648367,7	MCF-7	breast:

Variant related genes	Relation type
ENSG00000143878	Chromatin interaction

Extended variants
information (count: 8 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:2)

rs_ID	r²[population]
rs2286982	1.00[AFR][1000 genomes]
rs7043	1.00[AFR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:6 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv455830	chr2:20621404-20659862	Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	77 gene(s)	inside rSNPs	diseases
2	nsv581166	chr2:20621404-20659862	Enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	77 gene(s)	inside rSNPs	diseases
3	nsv873717	chr2:20625174-20756900	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	90 gene(s)	inside rSNPs	diseases
4	nsv873718	chr2:20627875-20752152	Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	90 gene(s)	inside rSNPs	diseases
5	nsv873719	chr2:20628882-20756900	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	90 gene(s)	inside rSNPs	diseases
6	nsv833537	chr2:20630092-20826816	Enhancers Weak transcription Flanking Active TSS Genic enhancers Strong transcription Transcr. at gene 5' and 3' Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	96 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:34 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:20623600-20631600	Weak transcription	Liver	Liver
2	chr2:20624800-20633400	Enhancers	Primary monocytes fromperipheralblood	blood
3	chr2:20625000-20646000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
4	chr2:20625400-20631800	Weak transcription	Colonic Mucosa	Colon
5	chr2:20625400-20639200	Weak transcription	Esophagus	oesophagus
6	chr2:20626000-20634400	Weak transcription	Breast Myoepithelial Primary Cells	Breast
7	chr2:20628600-20631600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
8	chr2:20629000-20631400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
9	chr2:20629000-20631400	Enhancers	HSMM	muscle
10	chr2:20629200-20631400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
11	chr2:20629200-20631400	Enhancers	NHEK	skin
12	chr2:20629200-20632000	Enhancers	K562	blood
13	chr2:20629200-20643400	Weak transcription	Right Atrium	heart
14	chr2:20629400-20632400	Weak transcription	Duodenum Mucosa	Duodenum
15	chr2:20629600-20631400	Enhancers	HMEC	breast
16	chr2:20629600-20632200	Weak transcription	Colon Smooth Muscle	Colon
17	chr2:20629800-20632000	Weak transcription	Stomach Smooth Muscle	stomach
18	chr2:20630000-20632400	Weak transcription	Sigmoid Colon	Sigmoid Colon
19	chr2:20630200-20631800	Weak transcription	Placenta	Placenta
20	chr2:20630200-20632000	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
21	chr2:20630200-20638200	Weak transcription	Fetal Muscle Leg	muscle
22	chr2:20630600-20638000	Weak transcription	Skeletal Muscle Male	skeletal muscle
23	chr2:20630600-20644800	Weak transcription	Lung	lung
24	chr2:20630800-20631800	Weak transcription	Adipose Nuclei	Adipose
25	chr2:20630800-20631800	Enhancers	HepG2	liver
26	chr2:20631000-20631800	Weak transcription	Primary hematopoietic stem cells short term culture	blood
27	chr2:20631000-20631800	Weak transcription	Skeletal Muscle Female	skeletal muscle
28	chr2:20631000-20632200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
29	chr2:20631000-20632200	Weak transcription	Pancreas	Pancrea
30	chr2:20631000-20633200	Enhancers	Monocytes-CD14+_RO01746	blood
31	chr2:20631000-20637600	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
32	chr2:20631000-20637800	Weak transcription	Psoas Muscle	Psoas
33	chr2:20631000-20639200	Weak transcription	Gastric	stomach
34	chr2:20631200-20637200	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links